C
C8 MediSensors
Glucose monitoring for diabetics
About C8 MediSensors
C8 MediSensors, founded in 2003 by Robert McNamara, was a San Jose-based company focused on developing a non-invasive continuous glucose monitor (nCGM) for individuals with diabetes. The company's creation was personally motivated, as one of the co-founders was a father seeking a better solution for his son's diabetes management.
The core of C8 MediSensors' approach was its Optical Glucose Monitor System, which utilized Raman spectroscopy. This technology involved shining a beam of light onto the skin; the resulting vibrations from glucose molecules would be measured to provide a glucose reading. This method was designed to be a painless alternative to traditional invasive CGMs that require a sensor inserted under the skin. The device was a small, portable monitor worn against the skin on the abdomen, intended to take measurements automatically every ten minutes and transmit the data wirelessly to a smartphone for discreet monitoring.
The company successfully raised a total of $69.4 million over 10 funding rounds, with notable investors including General Electric and the San Jose Redevelopment Agency. A significant milestone was achieved in October 2012, when C8 MediSensors received European CE Mark approval, allowing the device to be marketed in Europe. The company planned to launch the product in Europe in the latter half of 2012. However, despite its promising technology and initial regulatory success, C8 MediSensors is now considered a deadpooled company.
Source: Dealroom company dataAt a glance
- Status
- Closed
- Founded
- 2003
- Headquarters
- San Jose, United States
- Employees
- 14
- Open positions
- None listed
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Personal Health, Diabetes, Biotechnology, Medical Systems, Hard Tech, DT and LS, science-based
- Technology
- Deep Tech, Recognition Technology
- Business model
- Manufacturing
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Jun 2012 | $19M | $76M | GE Ventures | — |
| SERIES COther financing | Feb 2012 | $24M | $96M | GE Ventures | — |
Growth signals
Latest recorded traffic for C8 MediSensors is 0 monthly website visits. C8 MediSensors's team declined 17.6% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
C8 MediSensors in the San Jose ecosystem
The C8 MediSensors office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
GE Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about C8 MediSensors on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See C8 MediSensors’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








